GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » 12-1 Month Momentum %

Lushang Freda Pharmaceutical Co (SHSE:600223) 12-1 Month Momentum % : -4.76% (As of Apr. 26, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-04-26), Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % is -4.76%.

The industry rank for Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % or its related term are showing as below:

SHSE:600223's 12-1 Month Momentum % is ranked worse than
56.3% of 1842 companies
in the Real Estate industry
Industry Median: 0.345 vs SHSE:600223: -4.76

Competitive Comparison of Lushang Freda Pharmaceutical Co's 12-1 Month Momentum %

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % falls into.


;
;

Lushang Freda Pharmaceutical Co  (SHSE:600223) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lushang Freda Pharmaceutical Co  (SHSE:600223) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Lushang Freda Pharmaceutical Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lushang Freda Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Executives
Li Hang senior management
Yin Wei Directors, senior managers
Shao Zhao Wei senior management
Wang Zhong Wu senior management
Dong Hong Lin Director
Zhou Hong Bo senior management
Li Lu senior management
Liu Zeng Wei senior management
Zhang Quan Li senior management
Xu Tao senior management
Ju Hai Bo Director
Zhao Xi Liang Director
Pi Xi Cai Supervisors

Lushang Freda Pharmaceutical Co Headlines

No Headlines